000 01263 a2200337 4500
005 20250517102740.0
264 0 _c20170516
008 201705s 0 0 eng d
022 _a1474-4457
024 7 _a10.1016/S1473-3099(16)30132-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDodd, Peter J
245 0 0 _aGlobal burden of drug-resistant tuberculosis in children: a mathematical modelling study.
_h[electronic resource]
260 _bThe Lancet. Infectious diseases
_c10 2016
300 _a1193-1201 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntitubercular Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aGlobal Health
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aIsoniazid
_xtherapeutic use
650 0 4 _aModels, Theoretical
650 0 4 _aMycobacterium tuberculosis
_xisolation & purification
650 0 4 _aTuberculosis, Multidrug-Resistant
_xdrug therapy
700 1 _aSismanidis, Charalambos
700 1 _aSeddon, James A
773 0 _tThe Lancet. Infectious diseases
_gvol. 16
_gno. 10
_gp. 1193-1201
856 4 0 _uhttps://doi.org/10.1016/S1473-3099(16)30132-3
_zAvailable from publisher's website
999 _c26159704
_d26159704